Sign inJoin waitlistJoin the waitlist

Maya Fayfman

Physician · Emory University School of Medicine

Credentials: · · · · ·

History

Emory University School of Medicine
Present

Endocrinology, Diabetes, and Metabolism
Emory University School of Medicine
2013–2015
Emory University School of Medicine
2011–2015
Internal Medicine
Tufts Medical Center
2010–2013

Research

Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Review · Medical Clinics of North America · 2017 · First of 3 authors · 168 citations
Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study
Diabetes Care · 2020 · 113 citations
Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial
Diabetes Care · 2022 · 97 citations

GU
Guillermo Umpierrez
35 papers · 19 as a fellow
Francisco Pasquel
28 papers
Priyathama Vellanki
23 papers
RG
Rodolpho Galindo
19 papers · 6 as a fellow
Georgia Davis
15 papers · 4 as a fellow
AM
Alexandra Migdal
9 papers
Bonnie Albury
8 papers · 1 as a resident
SH
Sonya Haw
8 papers
Gabriel Santamarina
7 papers
Ravi Rajani
7 papers
Maria Urrutia
6 papers
DR
David Reyes-Umpierrez
5 papers · 4 as a fellow

Grants

Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-Foot-Nav), a Randomized Controlled Trial
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.1M · Emory University
2025–2030
Use of Non-Insulin Agents in Hospitalized Patients with Type 2 Diabetes (T2D)
National Institute of Diabetes and Digestive and Kidney Diseases · K23
Contact PI · $870K · Emory University
2020–2026
Randomized Controlled Trial of Continuous Glucose Monitoring Compared to Point of Care Glucose Testing Following Hospital Discharge on 12-Week Diabetic Foot Ulcer Healing Rates
National Institute of Diabetes and Digestive and Kidney Diseases · R03
Contact PI · $191.7K · Emory University
2023–2025

Clinical trials

CGM and DFU Healing Post-discharge
Principal investigator · Completed
Emory University
2024–2026
Oral Anti Diabetic Agents in the Hospital
Principal investigator · Terminated · Phase 4
Emory University
2020–2025
Sitagliptin in Non-Diabetic Patients Undergoing General Surgery
Principal investigator · Completed · Phase 4
Emory University
2016–2017
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
Site PI · Recruiting
University of Michigan
2023–2028